Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America

ABSTRACT: The use of biosimilar drugs for multiple sclerosis (MS) has become widespread in Latin America, with the goal of reducing costs of treatments, promoting the sustainability of healthcare systems, and improving patient access to these therapies. There is currently a need to define and comply...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinberg, Judith, Fragoso, Yara D., Duran Quiroz, Juan Carlos, García, Juan Raul, Guerra, Caroline, Rodriguez, Virginia, Carcamo Rodriguez, Claudia, Ciampi, Ethel, Correa-Diaz, Edgar, Macías, Miguel, Novarro, Nelson, Vizcarra, Darwin, Oehninger Gatti, Carlos, Orozco, Geraldine, Carrá, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858893/
https://www.ncbi.nlm.nih.gov/pubmed/31127566
http://dx.doi.org/10.1007/s40120-019-0139-y

Ejemplares similares

Ejemplares similares